Chapter 4.2 Flashcards
- State the mechanism of action of the following drugs used to treat spasticity: diazepam
increases GABA mediated inhibition
baclofen MOA
stimulates GABA receptors in spinal cord
tizanidine MOA
bind to alpha 2 receptors found primarily in CNS inhibiting small interneurons in neuronal pathways reducing activity of alpha motor neuron
gabapentin MOA
inhibits calcium entry in presynaptic terminals decreasing release of glutamate and other excitatory neurotransmitters
dantrolene sodium MOA
inhibits release of calcium from skeletal muscle sarcoplasmic reticulum
botulinum toxin MOA
injected locally for severe spasms and is a muscle paralytic. Mechanism is inhibits Ach release at skeletal NMJ
- State the other pharmacologic actions of diazepam that may be useful in treating patients with spasticity.
helpful with spasticity and anxiety
- State the location for the intrathecal administration of baclofen.
subarachnoid space and is used for intense spasticity
- State the patient populations primarily targeted for gabapentin therapy of spasticity.
MS, spinal cord injury
- State the patient populations primarily targeted for botulinum toxin therapy for spasticity.
pasmodic torticollis, blepharospasm, laryngeal dystonia, strabismus, and several other types of focal dystonias
- Identify the time course of botulin toxin activity in a patient with spasticity.
3-7 days and lasts 2-3 months
- List the key adverse effects associated with the following drugs used to treat spasticity: diazepam
sedation
baclofen
decreasing excitation of alpha motor neurons and sedation
gabapentin
may cause sedation, dizziness and ataxia
dantrolene
liver toxicity
botulinum toxin
Carry over and long term effects on reflex activity in CNS. May cause death if it reaches the blood stream because it paralyzes all muscles
- List some of the problems that may arise when a patient is using intrathecal baclofen via a pump delivery system
pump malfunction or a problem with the delivery catheter can occur. tolerance could develop with long-term, continuous baclofen administration.
- State some of the benefits of botulinum toxin therapy when spastic dominance of a muscle group is reduced.
increased residual function like gait or posture, improved ADL, improved bracing
- List the signs and symptoms of intrathecal baclofen overdose or withdrawal.
signs of overdose: decreased respiration and cardiac function, stupor and coma
Signs of withdrawal: fever, confusion, hallucinations and seizures
- List the problems and limitation of botulinum toxin therapy.
local irritation at injection site, potential for antibody production, and signs of OD like drooping eyes, difficulty speak and swallowing, muscle weakness and respiratory distress
- State the considerations of a physical therapy working with patients being treated for spasticity.
weakness, sedation and drastic change in muscle tone